U.K. life-science business Provexis PLC (PXS.LN) has appointed John Clarke, a former executive at GlaxoSmithKline PLC (GSK.LN), as a non-executive director, it said Monday.

Clarke, who worked at GlaxoSmithKline for more than 35 years, starts his position immediately.

Provexis chairman Dawson Buck said: "[Clarke's] proven success and in-depth knowledge in the consumer healthcare and sports nutrition sectors will be an important factor as we take Provexis to its next level of development."

"I believe the recently acquired Science in Sport brand has significant growth potential and I look forward to assisting Provexis in achieving its true potential," Clarke said.

Provexis, which specializes in food and sports nutrition technologies, bought Science in Sport Ltd., a sports nutrition business, for GBP8 million last June.

At 1010 GMT, Provexis shares flat at 1.7 pence.

-By Jana Weigand, Dow Jones Newswires; 44-20-7842-9314; jana.weigand@dowjones.com

Provexis (LSE:PXS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Provexis Charts.
Provexis (LSE:PXS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Provexis Charts.